Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03877497 · ClinicalTrials.gov registry record · NA
To Reach Unrestricted Services for Transgender Women
A NA study of HIV and Substance Abuse, sponsored by University of Central Florida.
- Completed
- Registry status
- NA
- Development phase
- 86
- Enrollment target
- 2
- Study locations
NCT03877497: Completed NA study of HIV and Substance Abuse, sponsored by University of Central Florida.
NCT03877497 is a NA study of HIV and Substance Abuse that has completed, run by University of Central Florida. The registered enrollment target is 86 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (80% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03877497, a NA study of HIV and Substance Abuse, has completed, sponsored by University of Central Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
- 2
- Study locations
Study Summary
Florida has the fifth largest transgender population in the United States. Transgender women, particularly those of color, in the southern part of Florida are a marginalized population who are impacted by co-morbidities of substance abuse and HIV in their communities. The overall objective of the study is to use a vetted adapted brief intervention to stem the development of substance abuse in at-risk transgender women, and thereby increase primary and secondary prevention methods such as routine HIV screening, uptake of pre-exposure prophylaxis (PrEP) and use of non-occupational post-exposure prophylaxis (nPEP).
Primary Outcome
The rate of change of substance abuse incidence for both arms
Conditions Studied
Interventions
- BEHAVIORAL Adapted SBIRT-T for transgender women
Study Locations (2)
Florida
- Florida International University - Miami
- University of Central Florida - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2019-09-19 |
| Est. Completion | 2024-12-04 |
| Phase | NA |
What the finished NCT03877497 record still lists
NCT03877497 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 440-participant average among 303 other HIV trials with a reported enrollment target (80% lower).
The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Adapted SBIRT-T for transgender women is the first listed.
NCT03877497 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT03877497 about?
NCT03877497 is a clinical study titled "To Reach Unrestricted Services for Transgender Women". Florida has the fifth largest transgender population in the United States. Transgender women, particularly those of color, in the southern part of Florida are a marginalized population who are impacted by co-morbidities of substance abuse and HIV in their communities. The overall objective of the st...
What is the current status of trial NCT03877497?
This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2019-09-19. Estimated completion is 2024-12-04.
What conditions does trial NCT03877497 study?
This clinical trial studies the following conditions: HIV, Substance Abuse, Transgender Women.
What interventions are being tested in trial NCT03877497?
The interventions under investigation include: Adapted SBIRT-T for transgender women (BEHAVIORAL).
Who is sponsoring clinical trial NCT03877497?
This trial is sponsored by University of Central Florida, which has 91 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03877497 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03877497's enrollment target sits among peer trials
86 170th of 303 higher than 134 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI